Global Cancer Genetic Testing Market Size, Top Share, Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Cancer Genetic Testing Market Size Analysis

Global Cancer Genetic Testing Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Cytogenetic Testing/Chromosome Analysis
    1. By Value
  3. Biochemical Testing
    1. By Value
  4. Molecular Testing
    1. By Value
  5. DNA Sequencing
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Lung Cancer
    1. By Value
  3. Cervical Cancer
    1. By Value
  4. Ovarian Cancer
    1. By Value
  5. Prostate Cancer
    1. By Value
  6. Breast Cancer
    1. By Value
  7. Uterine Cancer
    1. By Value
3. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Clinics
    1. By Value
  3. Clinical Labs
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Cytogenetic Testing/Chromosome Analysis
    1. By Value
  3. Biochemical Testing
    1. By Value
  4. Molecular Testing
    1. By Value
  5. DNA Sequencing
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Lung Cancer
    1. By Value
  3. Cervical Cancer
    1. By Value
  4. Ovarian Cancer
    1. By Value
  5. Prostate Cancer
    1. By Value
  6. Breast Cancer
    1. By Value
  7. Uterine Cancer
    1. By Value
3. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Clinics
    1. By Value
  3. Clinical Labs
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Cytogenetic Testing/Chromosome Analysis
    1. By Value
  3. Biochemical Testing
    1. By Value
  4. Molecular Testing
    1. By Value
  5. DNA Sequencing
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Lung Cancer
    1. By Value
  3. Cervical Cancer
    1. By Value
  4. Ovarian Cancer
    1. By Value
  5. Prostate Cancer
    1. By Value
  6. Breast Cancer
    1. By Value
  7. Uterine Cancer
    1. By Value
3. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Clinics
    1. By Value
  3. Clinical Labs
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Cytogenetic Testing/Chromosome Analysis
    1. By Value
  3. Biochemical Testing
    1. By Value
  4. Molecular Testing
    1. By Value
  5. DNA Sequencing
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Lung Cancer
    1. By Value
  3. Cervical Cancer
    1. By Value
  4. Ovarian Cancer
    1. By Value
  5. Prostate Cancer
    1. By Value
  6. Breast Cancer
    1. By Value
  7. Uterine Cancer
    1. By Value
3. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Clinics
    1. By Value
  3. Clinical Labs
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Cytogenetic Testing/Chromosome Analysis
  1. By Value
3. Biochemical Testing
  1. By Value
4. Molecular Testing
  1. By Value
5. DNA Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Lung Cancer
  1. By Value
3. Cervical Cancer
  1. By Value
4. Ovarian Cancer
  1. By Value
5. Prostate Cancer
  1. By Value
6. Breast Cancer
  1. By Value
7. Uterine Cancer
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Clinics
  1. By Value
3. Clinical Labs
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Cytogenetic Testing/Chromosome Analysis
    1. By Value
  3. Biochemical Testing
    1. By Value
  4. Molecular Testing
    1. By Value
  5. DNA Sequencing
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Lung Cancer
    1. By Value
  3. Cervical Cancer
    1. By Value
  4. Ovarian Cancer
    1. By Value
  5. Prostate Cancer
    1. By Value
  6. Breast Cancer
    1. By Value
  7. Uterine Cancer
    1. By Value
3. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Clinics
    1. By Value
  3. Clinical Labs
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Cancer Genetic Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Hoffmann-La Roche Ltd
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
QIAGEN N.V.
Myriad Genetics, Inc.
Abbott
ThermoFisher Scientific, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc
Danaher
PerkinElmer
Agilent Technologies, Inc
Quest Diagnostics
Luminex Corporation

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment